Myomo (MYO) Return on Capital Employed Growth (5y) (2022 - 2025)
Myomo (MYO) Return on Capital Employed Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn |
| 10 | Myomo | 43.85 Mn | 24.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5,219.00 |
| Jun 30, 2025 | 6,671.00 |
| Mar 31, 2025 | 14,229.00 |
| Dec 31, 2024 | 40,684.00 |
| Sep 30, 2024 | 10,314.00 |
| Jun 30, 2024 | 3,353.00 |
| Mar 31, 2024 | 3,869.00 |
| Dec 31, 2023 | 5,712.00 |
| Sep 30, 2023 | 1,003.00 |
| Jun 30, 2023 | -2,945.00 |
| Mar 31, 2023 | -7,587.00 |
| Dec 31, 2022 | -6,415.00 |
| Sep 30, 2022 | -420.00 |